WO2006025013A1 - Electronically controlled pill and system for delivering at least one medicament - Google Patents
Electronically controlled pill and system for delivering at least one medicament Download PDFInfo
- Publication number
- WO2006025013A1 WO2006025013A1 PCT/IB2005/052820 IB2005052820W WO2006025013A1 WO 2006025013 A1 WO2006025013 A1 WO 2006025013A1 IB 2005052820 W IB2005052820 W IB 2005052820W WO 2006025013 A1 WO2006025013 A1 WO 2006025013A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dispensing
- medicament
- valve
- timing
- timing circuitry
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 135
- 239000006187 pill Substances 0.000 title abstract description 68
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 13
- 230000007246 mechanism Effects 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 4
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical compound CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000032529 Accidental overdose Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
Definitions
- the present invention relates generally to medication delivery systems. More particularly, it relates to an electronically controlled pill and system for delivering at least one medicament.
- a medicament is generally administered as a pill or a liquid to be taken at least one time per day.
- a person may be required to take or be administered several medicaments each day during the same or different times. This requires that the person or his caregiver maintain a log or remember which medicaments to take or administer at different times during the day.
- GI gastrointestinal
- Several medicaments are available as time-release capsules for releasing portions of the medicament into the body at different times. Time-release capsules utilize chemical reactions between chemical substances in the gastrointestinal tract and the coating of the capsules for dissolving and releasing the medicament. Food, particularly proteins and fats, and the GI chemistry affect the speed of the journey of medicaments through the stomach. As such, medicaments, including medicaments available as time-release capsules, do not follow an exactdispensing or dissolving pattern while traveling through the GI tract.
- one person may have more than a "normal" amount of chemical substances in the gastrointestinal tract due to a condition, an earlier-administered medicament, etc. and therefore, cause the coating of the time-release capsule to react quicker than normal. Accordingly, the medicament is released by the time-release capsule at a faster rate than an intended rate.
- another person may have less than the "normal" amount of chemical substance in the gastrointestinal tract and cause the coating of the time-release capsule to react slower than normal, thereby releasing the medicament at a slower rate than the intended rate.
- time- release capsules require a person or caregiver maintain a log or remember which medicaments to take or administer at different times during the day.
- some medicaments must be taken at bedtime, such as NSAIDS for rheumatoid arthritis, to produce fewer gastrointestinal complications, such as indigestion.
- Other medicaments such as the anti-inflammatory corticosteroid medication predisone, can cause insomnia when taken in high doses, and are typically taken in the morning.
- other medicaments, such as antihistamines are typically taken in the evening to prepare for symptoms that often occur in the morning.
- the present invention provides an electronically controlled pill or medicament delivery system for delivering or dispensing a medicament according to a preset dispensing timing pattern while traversing through the gastrointestinal tract.
- the preset dispensing timing pattern is fixed and is not susceptible to a person's physiological processes and conditions, mood, earlier-administered medicaments, etc.
- the electronically controlled pill includes control and timing circuitry for controlling the opening and closing of a valve or hatch according to the preset dispensing timing pattern for dispensing a medicament stored within a medicament reservoir of the pill.
- the electronically controlled pill allows a person to take all pills substantially simultaneously, at say 7:00 am, so that no more pills are required for the day. Medication that does not fit into one electronically controlled pill can be coordinated with other electronically controlled pills for the full day's pay load regimen.
- all of the medicaments required to be taken during a particular time period can be provided within one or more electronically controlled pills which can all be taken at the same time.
- the electronically controlled pills can have different dispensing timing patterns, so that a full day's coverage can be obtained.
- the present invention also provides a treatment system for administering two or more medicaments at the same time via the one or more electronically controlled pills.
- Each pill has an independent, preset dispensing timing pattern in order to dispense its medicaments within the body according to a dispensing pattern.
- the dispensing pattern can be varied from person to person depending on each person's physical condition, age, gender, ailments, etc.
- the electronically controlled pills present in the body may be programmed to stop dispensing medicament, in the expectation that a new set of pills will be taken. This prevents accidental overdose by having only the most recently taken pills dispensing medicament in the body.
- the treatment system of the present invention enables an individual to take all of his medicaments at substantially the same time, e.g., in the morning or in the evening, and not at different times during a particular time period (e.g., a 24-hour period).
- the treatment system of the present invention further enables a caregiver to administer once per day (i.e., once per a 24-hour period) all of the medicaments for each patient of a hospital or resident of a nursing home (or animals in a shelter or veterinary facility).
- the system of the present invention therefore avoids the need for a caregiver to wake up or otherwise disturb a patient or resident for the sole purpose of administering a medicament, or to track down a patient or resident who may be in a different part of the hospital or nursing home for the sole purpose of administering a medicament.
- the system of the present invention also reduces the overload required for inventorying, ordering, tracking and logging the medicaments.
- FIG. 1 is a schematic diagram of an electronically controlled pill in accordance with the present invention
- FIG. 2 is a chart illustrating an exemplary preset dispensing timing pattern for the electronically controlled pill in accordance with the present invention
- FIG. 3 is a schematic diagram of the electronically controlled pill dispensing a medicament in accordance with the present invention.
- FIG. 4 is a diagram of a kit having a plurality of electronically controlled pills tailored for administration to a particular individual.
- An electronically controlled pill or medicament delivery system according to the present invention is shown by FIG. 1, and further described with specificity hereinafter.
- the electronically controlled pill 100 is a self-contained, electronically controlled medicine delivery system. As described in detail below, the electronically controlled pill 100 includes programmed electronics that control a release mechanism according to a dispensing pattern for dispensing a medicament.
- the pill 100 is made from bio ⁇ compatibles materials such that the pill 100 is bio-compatible for at least the amount of time it requires to traverse the gastrointestinal tract.
- the bio-compatible materials are preferably stable in room temperature, such that the pill has a long shelf life.
- the word “medicament” refers to medicines, non-medicinal substances, contrast agents, gases, fluids, liquids, chemicals, radiological agents, imaging markers, sensors for monitoring the person's vitals, etc.
- the electronically controlled pill 100 includes an outer shell or housing 102; a medicament reservoir 104 for storing a medicament; an electronically controlled release valve or hatch 106 for dispensing the medicaments stored in the medicament reservoir 104; control and timing circuitry 108 for opening and closing the valve 106; and a battery 109.
- the control and timing circuitry 108 opens and closes the valve 106 throughout a dispensing time period in accordance with a preset dispensing timing pattern as further described below.
- the preset dispensing timing pattern is pre-programmed and is not susceptible to a person's physiological processes and conditions, mood, earlier- administered medicaments, etc.
- the shell 102 is preferably manufactured from materials used to fabricate implantable devices, including pacemaker leads and cardiac prosthesis devices, such as artificial hearts, heart valves, intraaortic balloons, and ventricular assist devices. These materials include Pellethane® 2363 polyetherurethane series of materials available from Dow Chemical Company and Elasthane polyetherurethane available from the Polymer Technology Group, Inc.. Other materials include PurSil® and CarboSil® also available from the Polymer Technology Group, Inc. The amount that the valve 106 is opened at each moment in time (e.g., each second) of the dispensing time period is dependent upon the preset dispensing timing pattern which is programmed within timing circuitry 110 of the control and timing circuitry 108.
- the dispensing time period is defined as the time period from when the electronically controlled pill 100 is placed in a person's mouth to the time all of the medicament stored within the medicament reservoir 104 has been dispensed, or the day (24-hour period) has expired. This 24-hour period may be shifted slightly to account for differences in absorption in the stomach versus the colon.
- valve 106 is kept open by the control and timing circuitry 108 to provide a fixed valve opening (or frequency of opening) for dispensing a predictable quantity of the medicament at each moment in time of dispensing time periods A, D and F. Approximately the same amount of medicament is dispensed at each moment in time during dispensing time periods A and F. During dispensing time period D, a higher quantity of medicament is dispensed than during dispensing time periods A and F.
- dispensing time periods B, C and E as shown by FIG. 2, different quantities of the medicament are dispensed at each moment in time. Therefore, during dispensing time periods B, C and E, the valve opening is varied accordingly by the control and timing circuitry 108 to dispense a quantity of the medicament varying at each moment in time.
- dispensing time period B the quantity of medicament dispensed during each moment in time is increased compared to the previous moment in time; whereas during dispensing time periods C and E, the quantity of medicament dispensed during each moment in time is decreased compared to the previous moment in time.
- the control and timing circuitry 108 is programmed for closing the valve 106 and controlling the amount the valve 106 is opened for controlling the size of the valve opening.
- the electronically controlled pill 100 can precisely control the quantity of medicament released during each moment in time (e.g., each second) of the dispensing time period.
- the preset dispensing timing pattern may be varied from one electronically controlled pill 100 to another by programming the control and timing circuitry 108 of each pill 100 to have a different preset dispensing timing pattern. Therefore, two individuals can be administered the same medicament utilizing two different preset dispensing timing patterns.
- the timing patterns can be determined using a look-up table which correlates one or more characteristics of a person with one or more preset dispensing timing patterns.
- a look-up table can correlate at least one of age, gender, weight, etc. with preset dispensing timing patterns.
- the person would then be administered an electronic pill 100 which is programmed with one of the determined preset dispensing timing patterns. Accordingly, the pill 100 of the present invention enables the same medicament to be administered to different individuals using different dispensing timing patterns.
- the preset dispensing timing patterns are a way to reduce the number of pills taking during a particular time period, e.g., a 24-hour period. All of the medicament required to be administered during the particular time period to an individual can be provided in one pill 100 having a preset dispensing timing pattern for dispensing the medicament according to predetermined quantities during the particular time period. If the payload in one pill is insufficient, then two electronically controlled pills are used to dispense the same medicament, where one pill does not start dispensing the medicament until the other pill has dispensed its medicament, i.e., its dispensing time period has lapsed or ended. Further, the present invention reduces the amount of labor required to administer pills in places like hospitals, nursing homes and veterinary facilities. By reducing the number of times that pills are administered, the number of medicament administration errors can also be reduced.
- control and timing circuitry 108 includes timing circuitry 110 programmed with the preset dispensing timing pattern, a start timer mechanism 112, a release controller 114 and a pressure mechanism 116.
- the start timer mechanism 112 enables activation of the timing circuitry 110.
- the battery 109 powers the control and timing circuitry 108 in order for each of the electromechanical components to operate during the dispensing time period.
- the start timer mechanism 112 is a micro- electromechanical (MEM) mechanism having a sensor 118 for sensing the presence of a liquid, such as water, saliva, etc.
- a liquid such as water, saliva, etc.
- the sensor 118 senses the presence of a liquid, and transmits an electrical signal to the timing circuitry 110.
- the start timer mechanism is a button which is pushed to transmit the electrical signal to the timing circuitry 110. The button is pushed just before the pill 100 is administered to a person or animal.
- this can be achieved by dissolving a thin, water soluble coating that separates two electrical contacts, enabling the switch to close the circuit.
- the switch is manually triggered by the patient or caregiver.
- the timing circuitry 110 Upon receiving the electrical signal, the timing circuitry 110 begins to clock the dispensing time period and control the release controller 114 by transmitting a signal thereto.
- the timing circuitry 110 includes a microprocessor programmed with the preset dispensing timing pattern for relaying the signal to the release controller 114, such that the medicament is dispensed during the dispensing time period substantially according to the preset dispensing timing pattern, such as the one shown by FIG. 2.
- the voltage level of the signal relays the size of the valve opening for controlling the quantity of the medicament dispensed at each moment of the dispensing time period substantially according to the preset dispensing timing pattern as shown by FIG. 2.
- the signal transmitted by the timing circuitry 110 to the release controller 114 only relays the opening and closing of the valve 106 and not the size of the valve opening.
- the release controller 114 is preferably a micro-electromechanical mechanism capable of receiving the signal from the timing circuitry and generating a signal having a variable voltage level to the electronically controlled valve 106 for closing the valve 106 and controlling the size of the valve opening or degree of opening of the valve 106 (in accordance with the voltage level of the received signal).
- the release controller 114 is a transistor or D/A circuit that provides voltages to the valve 106 causing it to open or close.
- the electronically controlled valve 106 is preferably a micro-electromechanical mechanism capable of being electrically controlled by a signal having a variable voltage levels. Each voltage level corresponds to a different size opening for the valve opening and one voltage level (or no voltage at all, i.e., no signal) corresponds to the valve 106 being closed.
- the valve 106 is similar in operation to valves used in ink-jet printers for dispensing ink in accordance with the amount that the valve is opened.
- the valve 106 is characterized as a microfluidic valve for controlling the movement of minute amount of liquids or gases in a miniaturized system.
- the reservoir 104 is a micro-syringe, whereby pressure applied to a plunger of the syringe dispenses the medicament via a needle tip of the micro- syringe which is in fluid communication with an opening in the shell 102.
- the opening replaces the valve 106.
- a check valve is placed at the needle tip of the micro-syringe to avoid leakage of the medicament during time periods within the dispensing time period where there should be no dispensing according to the preset dispensing timing pattern, and/or for controlling the quantity of medicament dispensed during the dispensing time period.
- the pressure mechanism 116 is located outside the medicament reservoir 104 ensuring that the medicament is directed toward the valve 106.
- the pressure mechanism 116 is preferably a biodegradable spring as shown by FIGs. 1 and 3.
- the pressure mechanism 116 can also be another type of spring, a piston, or any mechanism for performing the function of the pressure mechanism 116. That is, for performing the function of applying pressure to a piston-type member 130 when the valve 106 is open to push the piston-type member 130 towards the valve 106. As the piston-type member 130 moves towards the valve 106 pressure within the reservoir 104 causes the medicament to be dispensed as shown by FIG. 3.
- the medicament reservoir 104 is kept under pressure to assure a proper quantity of medicament is dispensed in accordance with the degree of openness of the valve 106, without the need for the pressure mechanism 116.
- the pressure can be monitored by a pressure sensor which relays the monitored pressure to the control and timing circuitry 108. If the pressure is outside a predetermined range, the circuitry 108 can then adjust the valve opening to increase or decrease the pressure.
- the pressure of the reservoir 104 can be different for each medicament and can depend on the medicament's viscosity.
- a look-up table or other data structure can be assessed by the circuitry 108 which correlates pressure, degree of valve opening, and other parameters, such as period of time in the dispensing time period, for determining, for example, the degree of valve opening by knowing the pressure, and vice versa. Based on the information obtained by assessing the look-up table, the circuitry 108 can then adjust the pressure, the valve opening, etc. These adjustments can be made in order to substantially track the preset dispensing timing pattern programmed within the pill 100. According to the present invention, all of the medicaments required to be taken during a particular time period, for example, during a 24-hour period, can be provided within one or more electronically controlled pills 100 which can all be taken at the same time.
- a treatment system of the present invention provides for two or more medicaments to be administered at the same time via the one or more electronically controlled pills 100.
- Each pill 100 has an independent, preset dispensing timing pattern in order to dispense its medicaments within the body according to a dispensing pattern.
- the dispensing pattern can be varied from person to person depending on each person's physical condition, age, gender, ailments, etc.
- the treatment system of the present invention enables an individual to take all of his medicaments at substantially the same time, e.g., in the morning or in the evening, and not at different times during a particular time period (e.g., a 24-hour period).
- the treatment system of the present invention further enables a caregiver to administer once per day (Le., once per a 24-hour period) all of the medicaments for each patient of a hospital or resident of a nursing home (or animals in a shelter or veterinary facility).
- the system of the present invention therefore avoids the need for a caregiver to wake up or otherwise disturb a patient or resident for the sole purpose of administering a medicament, or to track down a patient or resident who may be in a different part of the hospital or nursing home for the sole purpose of administering a medicament.
- the present invention also provides a kit 200 as shown by FIG. 4 having two or more electronically controlled pills 100 packaged within a container 202.
- Each pill 100 is placed within an indenture or recess 201 of the container 202 and each pill 100 has an independent, preset dispensing timing pattern programmed therein.
- the pills 100 of the kit 200 are custom tailored for an individual (or animal), such that the individual or his caregiver can be provided with the container 202 by a physician, pharmacist, etc.
- a timing schedule 204 is provided inside the container indicating when each of the pills 100 of the kit 200 is to be taken, e.g., the time and day of the week.
- the timing schedule 204 includes an area 206 where a physician, pharmacist, etc. can write the time when the pills 100 for each particular day are to be taken, and circle am or pm.
- Two or more pills 100 may need to be taken at a particular time of a given day, as shown by FIG. 4, where each pill has a different medicament stored therein and a different preset dispensing timing pattern.
- an individual can take all of the pills 100 which are indicated to be taken at the particular time of the given day and not take any other pills 100 until the same time the following day.
- each of the pills 100 of the kit 200 has a programmed preset dispensing timing pattern, there is little or no concern that the medicaments from each pill 100 would interact with each other even though the pills 100 are taken at the same time. For example, one of the pills 100 of the kit 200 can start dispensing immediately, while another pill 100 of the kit 200 would not start dispensing until three hours later.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05781618A EP1796776A1 (en) | 2004-09-01 | 2005-08-29 | Electronically controlled pill and system for delivering at least one medicament |
JP2007529112A JP2008511370A (en) | 2004-09-01 | 2005-08-29 | Electronically controlled tablets and systems for delivering at least one drug |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60627604P | 2004-09-01 | 2004-09-01 | |
US60/606,276 | 2004-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006025013A1 true WO2006025013A1 (en) | 2006-03-09 |
Family
ID=35559422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2005/052820 WO2006025013A1 (en) | 2004-09-01 | 2005-08-29 | Electronically controlled pill and system for delivering at least one medicament |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1796776A1 (en) |
JP (1) | JP2008511370A (en) |
CN (1) | CN101010115A (en) |
WO (1) | WO2006025013A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008053396A2 (en) | 2006-10-31 | 2008-05-08 | Koninklijke Philips Electronics N.V. | Design of swallowable multi-nozzle, dosing device for releasing medicines in the gastrointesinal tract |
US8597278B2 (en) | 2006-06-23 | 2013-12-03 | MEDIMETRICS Personalized Drug Delivery B.V. | Medicament delivery system and process |
US8961498B2 (en) | 2008-06-25 | 2015-02-24 | Medimetrics Personalized Drug Delivery | Electronic pill comprising a plurality of medicine reservoirs |
US8990018B2 (en) | 2008-03-31 | 2015-03-24 | MEDIMETRICS Personalized Drug Delivery B.V. | Method of preparing a swallowable capsule comprising a sensor |
US9067011B2 (en) | 2008-06-19 | 2015-06-30 | MEDIMETRICS Personalized Drug Delivery B.V. | Device for delivery of powder like medication in a humid environment |
US9327076B2 (en) | 2004-08-27 | 2016-05-03 | Medimetrics Personalized Drug Delivery | Electronically and remotely controlled pill and system for delivering at least one medicament |
US9550050B2 (en) | 2006-09-25 | 2017-01-24 | MEDIMETRICS Personalized Drug Delivery B.V. | Medicament delivery apparatus |
US10046109B2 (en) | 2009-08-12 | 2018-08-14 | Progenity, Inc. | Drug delivery device with compressible drug reservoir |
US10537720B2 (en) | 2018-04-09 | 2020-01-21 | Vibrant Ltd. | Method of enhancing absorption of ingested medicaments for treatment of parkinsonism |
US10814113B2 (en) | 2019-01-03 | 2020-10-27 | Vibrant Ltd. | Device and method for delivering an ingestible medicament into the gastrointestinal tract of a user |
US10888277B1 (en) | 2017-01-30 | 2021-01-12 | Vibrant Ltd | Method for treating diarrhea and reducing Bristol stool scores using a vibrating ingestible capsule |
US10905378B1 (en) | 2017-01-30 | 2021-02-02 | Vibrant Ltd | Method for treating gastroparesis using a vibrating ingestible capsule |
US11020018B2 (en) | 2019-01-21 | 2021-06-01 | Vibrant Ltd. | Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user |
US11052018B2 (en) | 2019-02-04 | 2021-07-06 | Vibrant Ltd. | Temperature activated vibrating capsule for gastrointestinal treatment, and a method of use thereof |
US11478401B2 (en) | 2016-09-21 | 2022-10-25 | Vibrant Ltd. | Methods and systems for adaptive treatment of disorders in the gastrointestinal tract |
US11504024B2 (en) | 2018-03-30 | 2022-11-22 | Vibrant Ltd. | Gastrointestinal treatment system including a vibrating capsule, and method of use thereof |
US11510590B1 (en) | 2018-05-07 | 2022-11-29 | Vibrant Ltd. | Methods and systems for treating gastrointestinal disorders |
US11638678B1 (en) | 2018-04-09 | 2023-05-02 | Vibrant Ltd. | Vibrating capsule system and treatment method |
US12083303B2 (en) | 2019-01-21 | 2024-09-10 | Vibrant Ltd. | Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9355220B2 (en) | 2011-05-02 | 2016-05-31 | Omnicell, Inc. | Medication dispensing cabinet systems and methods |
US10762173B2 (en) | 2011-12-05 | 2020-09-01 | Omnicell, Inc. | System and method for managing inventory at dispensing units |
CN107374773B (en) * | 2017-08-31 | 2023-07-25 | 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心) | An automatic timing dog deworming collar |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797492A (en) * | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
US5167626A (en) * | 1990-10-02 | 1992-12-01 | Glaxo Inc. | Medical capsule device actuated by radio-frequency (RF) signal |
FR2794654A1 (en) * | 1999-06-08 | 2000-12-15 | Ct De Transfert Des Microtechn | Depositing substances in digestive tract of persons or animals by using ingestable module which has means of storing various substances and sequentially releasing them by clockwork or radio signal |
WO2003068061A1 (en) * | 2002-02-11 | 2003-08-21 | C.T.M. (Centre De Transfert Des Microtechniques) | Device that is used for delivering and/or intracorporeal sampling of substances |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005131012A (en) * | 2003-10-29 | 2005-05-26 | Olympus Corp | Capsule medication system |
-
2005
- 2005-08-29 EP EP05781618A patent/EP1796776A1/en not_active Withdrawn
- 2005-08-29 CN CNA2005800294235A patent/CN101010115A/en active Pending
- 2005-08-29 JP JP2007529112A patent/JP2008511370A/en active Pending
- 2005-08-29 WO PCT/IB2005/052820 patent/WO2006025013A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3797492A (en) * | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
US5167626A (en) * | 1990-10-02 | 1992-12-01 | Glaxo Inc. | Medical capsule device actuated by radio-frequency (RF) signal |
FR2794654A1 (en) * | 1999-06-08 | 2000-12-15 | Ct De Transfert Des Microtechn | Depositing substances in digestive tract of persons or animals by using ingestable module which has means of storing various substances and sequentially releasing them by clockwork or radio signal |
WO2003068061A1 (en) * | 2002-02-11 | 2003-08-21 | C.T.M. (Centre De Transfert Des Microtechniques) | Device that is used for delivering and/or intracorporeal sampling of substances |
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9327076B2 (en) | 2004-08-27 | 2016-05-03 | Medimetrics Personalized Drug Delivery | Electronically and remotely controlled pill and system for delivering at least one medicament |
US8597278B2 (en) | 2006-06-23 | 2013-12-03 | MEDIMETRICS Personalized Drug Delivery B.V. | Medicament delivery system and process |
US9550050B2 (en) | 2006-09-25 | 2017-01-24 | MEDIMETRICS Personalized Drug Delivery B.V. | Medicament delivery apparatus |
US8597279B2 (en) | 2006-10-31 | 2013-12-03 | Medimetrics Personalized Drug Delivery, Inc. | Swallowable multi-nozzle dosing device for releasing medicines in the gastrointestinal tract |
WO2008053396A2 (en) | 2006-10-31 | 2008-05-08 | Koninklijke Philips Electronics N.V. | Design of swallowable multi-nozzle, dosing device for releasing medicines in the gastrointesinal tract |
US8990018B2 (en) | 2008-03-31 | 2015-03-24 | MEDIMETRICS Personalized Drug Delivery B.V. | Method of preparing a swallowable capsule comprising a sensor |
US9067011B2 (en) | 2008-06-19 | 2015-06-30 | MEDIMETRICS Personalized Drug Delivery B.V. | Device for delivery of powder like medication in a humid environment |
US8961498B2 (en) | 2008-06-25 | 2015-02-24 | Medimetrics Personalized Drug Delivery | Electronic pill comprising a plurality of medicine reservoirs |
US10046109B2 (en) | 2009-08-12 | 2018-08-14 | Progenity, Inc. | Drug delivery device with compressible drug reservoir |
US12090112B2 (en) | 2016-09-21 | 2024-09-17 | Vibrant Ltd. | Methods and systems for adaptive treatment of disorders in the gastrointestinal tract |
US11478401B2 (en) | 2016-09-21 | 2022-10-25 | Vibrant Ltd. | Methods and systems for adaptive treatment of disorders in the gastrointestinal tract |
US10888277B1 (en) | 2017-01-30 | 2021-01-12 | Vibrant Ltd | Method for treating diarrhea and reducing Bristol stool scores using a vibrating ingestible capsule |
US10905378B1 (en) | 2017-01-30 | 2021-02-02 | Vibrant Ltd | Method for treating gastroparesis using a vibrating ingestible capsule |
US11504024B2 (en) | 2018-03-30 | 2022-11-22 | Vibrant Ltd. | Gastrointestinal treatment system including a vibrating capsule, and method of use thereof |
US10543348B2 (en) | 2018-04-09 | 2020-01-28 | Vibrant Ltd. | Method of enhancing absorption of ingested medicaments for treatment of an an ailment of the GI tract |
US11638678B1 (en) | 2018-04-09 | 2023-05-02 | Vibrant Ltd. | Vibrating capsule system and treatment method |
US10537720B2 (en) | 2018-04-09 | 2020-01-21 | Vibrant Ltd. | Method of enhancing absorption of ingested medicaments for treatment of parkinsonism |
US11510590B1 (en) | 2018-05-07 | 2022-11-29 | Vibrant Ltd. | Methods and systems for treating gastrointestinal disorders |
US10814113B2 (en) | 2019-01-03 | 2020-10-27 | Vibrant Ltd. | Device and method for delivering an ingestible medicament into the gastrointestinal tract of a user |
US12115330B2 (en) | 2019-01-03 | 2024-10-15 | Vibrant Ltd. | Device and method for delivering an ingestible medicament into the gastrointestinal tract of a user |
US11020018B2 (en) | 2019-01-21 | 2021-06-01 | Vibrant Ltd. | Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user |
US12083303B2 (en) | 2019-01-21 | 2024-09-10 | Vibrant Ltd. | Device and method for delivering a flowable ingestible medicament into the gastrointestinal tract of a user |
US11052018B2 (en) | 2019-02-04 | 2021-07-06 | Vibrant Ltd. | Temperature activated vibrating capsule for gastrointestinal treatment, and a method of use thereof |
Also Published As
Publication number | Publication date |
---|---|
EP1796776A1 (en) | 2007-06-20 |
JP2008511370A (en) | 2008-04-17 |
CN101010115A (en) | 2007-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1789128B1 (en) | Electronically and remotely controlled pill and system for delivering at least one medicament | |
WO2006025013A1 (en) | Electronically controlled pill and system for delivering at least one medicament | |
EP1819392B1 (en) | Electronically controlled pill | |
WO2009063377A1 (en) | Ingestible electronic capsule | |
KR101426340B1 (en) | Variable flow infusion pumps system | |
US7029455B2 (en) | Devices, systems and methods for patient infusion | |
US20090306633A1 (en) | Electronically controlled capsule | |
US20080194912A1 (en) | Electronically Controlled Ingestible Capsule for Sampling Fluids in Alimentary Tract | |
WO2009063375A1 (en) | Ingestible electronic capsule | |
US20180271752A1 (en) | Drug delivery capsules with external intelligence | |
US20080269664A1 (en) | System and Method For Controlling Traversal of an Igested Capsule | |
WO2011124711A1 (en) | Reminder programming device and method | |
WO2006077527A2 (en) | Electronically controlled capsule for releasing radiation | |
WO2006078672A1 (en) | Medical agent delivery system and method | |
JP2022517820A (en) | Devices and methods for delivering fluid ingestible agents into the user's gastrointestinal tract | |
WO2009063376A1 (en) | Ingestible electronic capsule | |
WO2016141288A1 (en) | Platform for delayed drug release within the gastrointestinal tract | |
CN112384186A (en) | Metering device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005781618 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007529112 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580029423.5 Country of ref document: CN Ref document number: 895/CHENP/2007 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005781618 Country of ref document: EP |